TrialAnnals of surgical oncology2013

Combined analysis of phase III trials evaluating [⁹⁹mTc]tilmanocept and vital blue dye for identification of sentinel lymph nodes in clinically node-negative cutaneous melanoma.

Vernon K Sondak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.